Abreu NJ, Waldrop MA (2021) Overview of gene therapy in spinal muscular atrophy and Duchenne muscular dystrophy. Pediatr Pulmonol 56(4):710–720

Article  PubMed  Google Scholar 

Ahmed N (2022) A systematic review of the efficacy of gene therapy for diabetes and diabetes-related complications

Ahmed R et al. (2025) CRISPR/Cas9 system as a promising therapy in Thalassemia and Sickle Cell Disease: a systematic review of clinical trials. Mol Biotechnol 1–10

Alhamadani F et al (2022) Adverse drug reactions and toxicity of the food and drug administration–approved antisense oligonucleotide drugs. Drug Metab Dispos 50(6):879–887

Article  CAS  PubMed  PubMed Central  Google Scholar 

Allemailem KS et al (2024) Recent updates of the CRISPR/Cas9 genome editing system: novel approaches to regulate its spatiotemporal control by genetic and physicochemical strategies. Int J Nanomed 19:5335–5363

Article  Google Scholar 

Almeida MJ, Matos A (2019) Designer nucleases: gene-editing therapies using CCR5 as an emerging target in HIV. Curr HIV Res 17(5):306–323

Article  CAS  PubMed  Google Scholar 

Alyousfi DM (2022) Development and application of methods for resolving molecular diagnoses from patient sequence data for monogenic diseases. University of Southampton

Anderson JT et al (2020) Context and number of noncanonical repeat variable diresidues impede the design of TALE proteins with improved DNA targeting. Protein Sci 29(2):606–616

Article  CAS  PubMed  Google Scholar 

Anzalone AV et al (2019) Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576(7785):149–157

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arjmand B et al (2020) The horizon of gene therapy in modern medicine: advances and challenges. Cell Biol Trans Med Stem Cells Regener Med 8:33–64

Google Scholar 

Ashfaq MA et al (2020) Post-transcriptional gene silencing: Basic concepts and applications. J Biosci 45(1):128

Article  CAS  PubMed  Google Scholar 

Aslesh T, Yokota T (2022) Restoring SMN expression: an overview of the therapeutic developments for the treatment of spinal muscular atrophy. Cells 11(3):417

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aslesh T, Maruyama R, Yokota T (2018) Skipping multiple exons to treat DMD—promises and challenges. Biomedicines 6(1):1

Article  PubMed  PubMed Central  Google Scholar 

Auffray C, Chen Z, Hood L (2009) Systems medicine: the future of medical genomics and healthcare. Genome Med 1:1–11

Article  Google Scholar 

Badwal AK, Singh S (2024) A comprehensive review on the current status of CRISPR based clinical trials for rare diseases. Int J Biol Macromol 134097

Bateman JF, Boot-Handford RP, Lamandé SR (2009) Genetic diseases of connective tissues: cellular and extracellular effects of ECM mutations. Nat Rev Genet 10(3):173–183

Article  CAS  PubMed  Google Scholar 

Bauer DE, Orkin SH (2015) Hemoglobin switching’s surprise: the versatile transcription factor BCL11A is a master repressor of fetal hemoglobin. Curr Opin Genet Dev 33:62–70

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bekaert B et al (2022) CRISPR/Cas gene editing in the human germline. Semin Cell Dev Biol 131:93–107

Article  CAS  PubMed  Google Scholar 

Bhattacharjee G et al (2022) Current approaches in CRISPR-Cas9 mediated gene editing for biomedical and therapeutic applications. J Control Release 343:703–723

Article  CAS  PubMed  Google Scholar 

Blighe K et al (2018) Gene editing in the context of an increasingly complex genome. BMC Genom 19:1–20

Article  Google Scholar 

Bloom KM (2013) Inactivation of Hepatitis B Virus CCCDNA Using Engineered Transcription Activator-Like Effector Nucleases. University of the Witwatersrand, Johannesburg (South Africa)

Google Scholar 

Burgess SM (2020) Genome editing by targeted nucleases and the CRISPR/Cas revolution. Liver Biol Pathobiol 953–964

Cakmak C, Zempel H (2021) A perspective on human cell models for POLG-spectrum disorders: advantages and disadvantages of CRISPR-Cas-based vs. patient-derived iPSC models. Med Gen 33(3):245–249

CAS  Google Scholar 

Carroll D (2014) Genome engineering with targetable nucleases. Annu Rev Biochem 83:409–439

Article  CAS  PubMed  Google Scholar 

Carter BJ (2004) Adeno-associated virus and the development of adeno-associated virus vectors: a historical perspective. Mol Ther 10(6):981–989

Article  CAS  PubMed  Google Scholar 

Cavazzana M et al (2024) Treating sickle cell disease: gene therapy approaches. Annual Rev Pharmacol Toxicol 65

Chandrasegaran S, Carroll D (2016) Origins of programmable nucleases for genome engineering. J Mol Biol 428(5):963–989

Article  CAS  PubMed  Google Scholar 

Chen S et al (2024) Splice-modulating antisense oligonucleotides as therapeutics for inherited metabolic diseases. BioDrugs 38(2):177–203

Article  CAS  PubMed  PubMed Central  Google Scholar 

Choi EH et al (2023) Genome editing in the treatment of ocular diseases. Exp Mol Med 55(8):1678–1690

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ciurea AV et al (2023) Unraveling molecular and genetic insights into neurodegenerative diseases: advances in understanding Alzheimer’s, Parkinson’s, and Huntington’s diseases and amyotrophic lateral sclerosis. Int J Mol Sci 24(13):10809

Article  CAS  PubMed  PubMed Central  Google Scholar 

Collins M, Thrasher A (1821) Gene therapy: progress and predictions. Proc Royal Soc B Biol Sci 2015(282):20143003

Google Scholar 

Conti RM et al (2021) Estimating the financial impact of gene therapy in the US

Council NR et al. (2011) Toward precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease

Cox DBT, Platt RJ, Zhang F (2015) Therapeutic genome editing: prospects and challenges. Nat Med 21(2):121–131

Article  CAS  PubMed  PubMed Central  Google Scholar 

Curran MA et al (2000) Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors. Mol Ther 1(1):31–38

Article  CAS  PubMed  Google Scholar 

Davidson EH et al (2002) A genomic regulatory network for development. Science 295(5560):1669–1678

Article  CAS  PubMed  Google Scholar 

Delhove J, Qasim W (2017) Genome-edited T cell therapies. Curr Stem Cell Rep 3(2):124–136

Article  PubMed  PubMed Central  Google Scholar 

Dongare DB, Nishad SS, Mastoli SY, Saraf SA, Srivastava N, Dey A (2025) High-throughput sequencing: a breakthrough in molecular diagnosis for precision medicine. Funct Integ Genom 25(1):1–23

Article  Google Scholar 

Duxbury MS, Whang EE (2004) RNA interference: a practical approach. J Surg Res 117(2):339–344

Article  CAS  PubMed  Google Scholar 

Egli M, Manoharan M (2023) Chemistry, structure and function of approved oligonucleotide therapeutics. Nucleic Acids Res 51(6):2529–2573

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ehrhardt A et al (2008) Episomal vectors for gene therapy. Curr Gene Ther 8(3):147–161

Article  CAS  PubMed  Google Scholar 

Eid A, Alshareef S, Mahfouz MM (2018) CRISPR base editors: genome editing without double-stranded breaks. Biochem J 475(11):1955–1964

Article  CAS